Literature DB >> 22518254

Trophic factors and stem cells for promoting recovery in stroke.

Guven Uzun1, Dawood Subhani, Srikureja Amor.   

Abstract

BACKGROUND: Stem cell therapy for stroke is in its initial stages as an option to restore lost neurological functions after stroke.
OBJECTIVE: To provide a comprehensive review of studies involving stem cells in stroke treatment and to highlight new evidence from the ongoing clinical trials.
METHODOLOGY: We performed a systematic study of various published journals in online medical libraries using Pubmed, Sciencedirect, and hajournal. Evidence synthesis is done with specific search words of - stem cell therapy, stroke, trophic factor, neural progenitor cell, pathophysiology, mechanism of action, clinical trial and mesenchymal stem cell in various combinations. Emphasis was given to articles published in year 2000 and onwards.
RESULTS: Current research on stem cell therapy for stroke focuses on transplantation and endogenous neurogenesis of stem cells in brain. The sub-ventricular zone in the adult brain is identified as an endogenous resource of neuronal precursors that can be recruited to adjacent lesioned areas. Several factors can increase adult neurogenesis by stimulating formation or improving survival of new neurons, such as FGF-2, EGF, stem cell factor, erythropoietin, BDNF, caspase inhibitors, and anti-inflammatory drugs. Much of the beneficial effects of stem cell in stroke models are related to secretion of trophic factors.
CONCLUSION: The complex pathophysiology involving various trophic factors, growth factor and gene modification in animal studies have showed promising result. Future research involving these trophic factors should open up new additional or clinically significant alternative for the treatment of stroke.

Entities:  

Keywords:  clinical trials; neural stem/progenitor cells; stroke; transplantation; trophic factors

Year:  2010        PMID: 22518254      PMCID: PMC3317290     

Source DB:  PubMed          Journal:  J Vasc Interv Neurol        ISSN: 1941-5893


  113 in total

Review 1.  Factors intrinsic to the neuron can induce and maintain its ability to promote axonal outgrowth: a role for BCL2?

Authors:  K Holm; O Isacson
Journal:  Trends Neurosci       Date:  1999-06       Impact factor: 13.837

2.  Pure red-cell aplasia and antierythropoietin antibodies in patients treated with recombinant erythropoietin.

Authors:  Nicole Casadevall; Joelle Nataf; Beatrice Viron; Amir Kolta; Jean-Jacques Kiladjian; Philippe Martin-Dupont; Patrick Michaud; Thomas Papo; Valerie Ugo; Irene Teyssandier; Bruno Varet; Patrick Mayeux
Journal:  N Engl J Med       Date:  2002-02-14       Impact factor: 91.245

3.  Erythropoietin and erythropoietin receptors in human CNS neurons, astrocytes, microglia, and oligodendrocytes grown in culture.

Authors:  A Nagai; E Nakagawa; H B Choi; K Hatori; S Kobayashi; S U Kim
Journal:  J Neuropathol Exp Neurol       Date:  2001-04       Impact factor: 3.685

Review 4.  The role of inflammation and cytokines in brain injury.

Authors:  B Arvin; L F Neville; F C Barone; G Z Feuerstein
Journal:  Neurosci Biobehav Rev       Date:  1996       Impact factor: 8.989

5.  Erythropoietin inhibits calcium-induced neurotransmitter release from clonal neuronal cells.

Authors:  M Kawakami; S Iwasaki; K Sato; M Takahashi
Journal:  Biochem Biophys Res Commun       Date:  2000-12-09       Impact factor: 3.575

6.  An essential role for NF-kappaB in preventing TNF-alpha-induced cell death.

Authors:  A A Beg; D Baltimore
Journal:  Science       Date:  1996-11-01       Impact factor: 47.728

7.  Time dependent amelioration against ischemic brain damage by glial cell line-derived neurotrophic factor after transient middle cerebral artery occlusion in rat.

Authors:  W R Zhang; T Hayashi; M Iwai; I Nagano; K Sato; Y Manabe; K Abe
Journal:  Brain Res       Date:  2001-06-08       Impact factor: 3.252

8.  Erythropoietin gene expression in human, monkey and murine brain.

Authors:  H H Marti; R H Wenger; L A Rivas; U Straumann; M Digicaylioglu; V Henn; Y Yonekawa; C Bauer; M Gassmann
Journal:  Eur J Neurosci       Date:  1996-04       Impact factor: 3.386

9.  Mobilized peripheral blood cells administered intravenously produce functional recovery in stroke.

Authors:  Alison E Willing; Martina Vendrame; Jennifer Mallery; C Jordan Cassady; Cyndy D Davis; Juan Sanchez-Ramos; Paul R Sanberg
Journal:  Cell Transplant       Date:  2003       Impact factor: 4.064

10.  Endogenous brain protection by granulocyte-colony stimulating factor after ischemic stroke.

Authors:  Sevgi Sevimli; Kai Diederich; Jan-Kolja Strecker; Matthias Schilling; Rainer Klocke; Sigrid Nikol; Friederike Kirsch; Armin Schneider; Wolf-Rüdiger Schäbitz
Journal:  Exp Neurol       Date:  2009-03-28       Impact factor: 5.330

View more
  7 in total

Review 1.  Current Neurogenic and Neuroprotective Strategies to Prevent and Treat Neurodegenerative and Neuropsychiatric Disorders.

Authors:  I M Carvalho; P B Coelho; P C Costa; C S Marques; R S Oliveira; D C Ferreira
Journal:  Neuromolecular Med       Date:  2015-09-15       Impact factor: 3.843

Review 2.  Regenerative therapy for neuronal diseases with transplantation of somatic stem cells.

Authors:  Hiroshi Kanno
Journal:  World J Stem Cells       Date:  2013-10-26       Impact factor: 5.326

Review 3.  Cell adhesion and long-term survival of transplanted mesenchymal stem cells: a prerequisite for cell therapy.

Authors:  Seahyoung Lee; Eunhyun Choi; Min-Ji Cha; Ki-Chul Hwang
Journal:  Oxid Med Cell Longev       Date:  2015-02-02       Impact factor: 6.543

4.  A Network-Based Method for Mechanistic Investigation and Neuroprotective Effect on Post-treatment of Senkyunolid-H Against Cerebral Ischemic Stroke in Mouse.

Authors:  Jie Zhang; Yunyao Jiang; Nan Liu; Ting Shen; Hyo Won Jung; Jianxun Liu; Bing Chun Yan
Journal:  Front Neurol       Date:  2019-12-19       Impact factor: 4.003

5.  Analgesic effect of recombinant GABAergic precursors releasing ω-conotoxin MVIIA in a model of peripheral nerve injury in rats.

Authors:  Stanislava Jergova; Melissa Hernandez; Jacqueline Sagen
Journal:  Mol Pain       Date:  2022-04       Impact factor: 3.370

6.  Effects of bone marrow-derived mesenchymal stem cells on the axonal outgrowth through activation of PI3K/AKT signaling in primary cortical neurons followed oxygen-glucose deprivation injury.

Authors:  Yong Liu; Yixian Zhang; Longzai Lin; Feifei Lin; Tin Li; Houwei Du; Ronghua Chen; Wei Zheng; Nan Liu
Journal:  PLoS One       Date:  2013-11-12       Impact factor: 3.240

7.  Ecto-domain phosphorylation promotes functional recovery from spinal cord injury.

Authors:  Kenji Suehiro; Yuka Nakamura; Shuai Xu; Youichi Uda; Takafumi Matsumura; Yoshiaki Yamaguchi; Hitoshi Okamura; Toshihide Yamashita; Yoshinori Takei
Journal:  Sci Rep       Date:  2014-05-15       Impact factor: 4.379

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.